From September 28, 2022 to September 30, 2022, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for KRW 0 million under the buyback announced on September 28, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29,050 KRW | +0.52% | -0.17% | +4.68% |
2023 | Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) dropped from S&P Global BMI Index | CI |
2023 | Daihan Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.68% | 12Cr | |
+15.91% | 4.2TCr | |
+22.40% | 2.23TCr | |
+18.48% | 1.52TCr | |
+16.12% | 1.4TCr | |
+45.12% | 1.21TCr | |
-9.58% | 679.6Cr | |
-0.05% | 678.76Cr | |
-8.87% | 572.55Cr | |
+14.18% | 549.33Cr |
- Stock Market
- Equities
- A023910 Stock
- News Daihan Pharmaceutical Co.,Ltd.
- Tranche Update on Daihan Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 28, 2022.